0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Poultry Coccidiosis Vaccines Market Research Report 2026
Published Date: 2026-01-22
|
Report Code: QYRE-Auto-3N19026
Home | Market Reports | Health| Health Conditions| Infectious Diseases
Global Poultry Coccidiosis Vaccines Market Research Report 2025
BUY CHAPTERS

Global Poultry Coccidiosis Vaccines Market Research Report 2026

Code: QYRE-Auto-3N19026
Report
2026-01-22
Pages:120
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Poultry Coccidiosis Vaccines Market Size

The global Poultry Coccidiosis Vaccines market was valued at US$ 129 million in 2025 and is anticipated to reach US$ 168 million by 2032, at a CAGR of 3.9% from 2026 to 2032.

Poultry Coccidiosis Vaccines Market

Poultry Coccidiosis Vaccines Market

The 2025 U.S. tariff policies introduce profound uncertainty into the global economic landscape. This report critically examines the implications of recent tariff adjustments and international strategic countermeasures on Poultry Coccidiosis Vaccines competitive dynamics, regional economic interdependencies, and supply chain reconfigurations.
Poultry Coccidiosis Vaccines are specialized vaccines designed to prevent coccidiosis in poultry, a parasitic disease caused by protozoa such as Eimeria species that infect the intestinal tract of chickens, turkeys, and other poultry. These vaccines stimulate the immune system of poultry to develop resistance against coccidiosis, effectively reducing disease incidence and improving growth performance and feed conversion rates. Poultry coccidiosis vaccines are a crucial tool for controlling this disease and offer a safer and more environmentally friendly alternative to traditional anticoccidial drugs, with the added benefit of reducing the risk of drug resistance. They are widely used in modern intensive poultry farming.
The North American market for Poultry Coccidiosis Vaccines is projected to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % over 2026–2032.
The Asia-Pacific market for Poultry Coccidiosis Vaccines is projected to rise from US$ million in 2025 to US$ million by 2032, at a CAGR of % over 2026–2032.
Major global manufacturers of Poultry Coccidiosis Vaccines include MSD Animal Health, Boehringer Ingelheim, HIPRA, Bioproperties, Huvepharma, Nisseiken, Biopharm, Ceva Santé Animale, Vaxxinova, Foshan Standard Biotech, etc. In 2025, the world's top three vendors accounted for approximately % of revenue.
This report delivers a comprehensive overview of the global Poultry Coccidiosis Vaccines market, with both quantitative and qualitative analyses, to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current market, and make informed business decisions regarding Poultry Coccidiosis Vaccines. The Poultry Coccidiosis Vaccines market size, estimates, and forecasts are provided in terms of sales volume (K Units) and revenue (US$ millions), with 2025 as the base year and historical and forecast data for 2021–2032.
The report segments the global Poultry Coccidiosis Vaccines market comprehensively. Regional market sizes by Type, by Application, , and by company are also provided. For deeper insight, the report profiles the competitive landscape, key competitors, and their respective market rankings, and discusses technological trends and new product developments.
This report will assist Poultry Coccidiosis Vaccines manufacturers, new entrants, and companies across the industry value chain with information on revenues, sales volume, and average prices for the overall market and its sub-segments, by company, by Type, by Application, and by region.
Market Segmentation

Scope of Poultry Coccidiosis Vaccines Market Report

Report Metric Details
Report Name Poultry Coccidiosis Vaccines Market
Accounted market size in 2025 US$ 129 million
Forecasted market size in 2032 US$ 168 million
CAGR 3.9%
Base Year 2025
Forecasted years 2026 - 2032
Segment by Type
  • Attenuated Vaccines
  • Non-attenuated Vaccines
by Application
  • Poultry
  • Other Animals
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company MSD Animal Health, Boehringer Ingelheim, HIPRA, Bioproperties, Huvepharma, Nisseiken, Biopharm, Ceva Santé Animale, Vaxxinova, Foshan Standard Biotech, Qilu Qingda Bio-Pharmaceutical, Skystar Bio-pharm, Hlinte, Guangdong Winsun Bio-pharmaceutical
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Defines the scope of the report and presents an executive summary of market segments (by Type, by Application, , etc.), including the size of each segment and its future growth potential. It offers a high-level view of the current market and its likely evolution in the short, medium, and long term.
  • Chapter 2: Provides a detailed analysis of the competitive landscape for Poultry Coccidiosis Vaccines manufacturers, covering pricing, sales and revenue shares, latest development plans, and mergers and acquisitions.
  • Chapter 3: Examines Poultry Coccidiosis Vaccines sales and revenue at the regional and country levels. It quantifies market size and growth potential for each region and its key countries, and outlines market development, outlook, addressable space, and national market size.
  • Chapter 4: Analyzes segments by Type, detailing the size and growth potential of each segment to help readers identify “blue ocean” opportunities.
  • Chapter 5: Analyzes market segments by Application, covering the size and growth potential of each segment to help readers identify “blue ocean” opportunities in downstream markets.
  • Chapter 6: Profiles key players, presenting core information on leading companies, including product sales, revenue, pricing, gross margin, product portfolio/introductions, and recent developments.
  • Chapter 7: Reviews the industry value chain, including upstream and downstream segments.
  • Chapter 8: Discusses market dynamics and recent developments, including drivers, restraints, challenges and risks for manufacturers, U.S. Tariffs and relevant policy analysis.
  • Chapter 9: Summarizes the key findings and conclusions of the report.

FAQ for this report

How fast is Poultry Coccidiosis Vaccines Market growing?

Ans: The Poultry Coccidiosis Vaccines Market witnessing a CAGR of 3.9% during the forecast period 2026-2032.

What is the Poultry Coccidiosis Vaccines Market size in 2032?

Ans: The Poultry Coccidiosis Vaccines Market size in 2032 will be US$ 168 million.

Who are the main players in the Poultry Coccidiosis Vaccines Market report?

Ans: The main players in the Poultry Coccidiosis Vaccines Market are MSD Animal Health, Boehringer Ingelheim, HIPRA, Bioproperties, Huvepharma, Nisseiken, Biopharm, Ceva Santé Animale, Vaxxinova, Foshan Standard Biotech, Qilu Qingda Bio-Pharmaceutical, Skystar Bio-pharm, Hlinte, Guangdong Winsun Bio-pharmaceutical

What are the Application segmentation covered in the Poultry Coccidiosis Vaccines Market report?

Ans: The Applications covered in the Poultry Coccidiosis Vaccines Market report are Poultry, Other Animals

What are the Type segmentation covered in the Poultry Coccidiosis Vaccines Market report?

Ans: The Types covered in the Poultry Coccidiosis Vaccines Market report are Attenuated Vaccines, Non-attenuated Vaccines

1 Poultry Coccidiosis Vaccines Market Overview
1.1 Product Definition
1.2 Poultry Coccidiosis Vaccines by Type
1.2.1 Global Poultry Coccidiosis Vaccines Market Value by Type: 2025 vs 2032
1.2.2 Attenuated Vaccines
1.2.3 Non-attenuated Vaccines
1.3 Poultry Coccidiosis Vaccines by Application
1.3.1 Global Poultry Coccidiosis Vaccines Market Value by Application: 2025 vs 2032
1.3.2 Poultry
1.3.3 Other Animals
1.4 Global Poultry Coccidiosis Vaccines Market Size Estimates and Forecasts
1.4.1 Global Poultry Coccidiosis Vaccines Revenue 2021–2032
1.4.2 Global Poultry Coccidiosis Vaccines Sales 2021–2032
1.4.3 Global Poultry Coccidiosis Vaccines Market Average Price (2021–2032)
1.5 Assumptions and Limitations
2 Poultry Coccidiosis Vaccines Market Competition by Manufacturers
2.1 Global Poultry Coccidiosis Vaccines Sales Market Share by Manufacturers (2021–2026)
2.2 Global Poultry Coccidiosis Vaccines Revenue Market Share by Manufacturers (2021–2026)
2.3 Global Poultry Coccidiosis Vaccines Average Price by Manufacturers (2021–2026)
2.4 Global Key Players of Poultry Coccidiosis Vaccines, Industry Ranking, 2023 vs 2024 vs 2025
2.5 Global Key Manufacturers of Poultry Coccidiosis Vaccines, Manufacturing Sites and Headquarters
2.6 Global Key Manufacturers of Poultry Coccidiosis Vaccines, Product Types and Applications
2.7 Global Key Manufacturers of Poultry Coccidiosis Vaccines, Date of Entry into the Industry
2.8 Global Poultry Coccidiosis Vaccines Market Competitive Situation and Trends
2.8.1 Global Poultry Coccidiosis Vaccines Market Concentration Rate
2.8.2 The Top 5 and Top 10 Global Poultry Coccidiosis Vaccines Players Market Share by Revenue
2.8.3 Global Poultry Coccidiosis Vaccines Market Share by Company Tier (Tier 1, Tier 2, Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Poultry Coccidiosis Vaccines Market Scenario by Region
3.1 Global Poultry Coccidiosis Vaccines Market Size by Region: 2021 vs 2025 vs 2032
3.2 Global Poultry Coccidiosis Vaccines Sales by Region: 2021–2032
3.2.1 Global Poultry Coccidiosis Vaccines Sales by Region: 2021–2026
3.2.2 Global Poultry Coccidiosis Vaccines Sales by Region: 2027–2032
3.3 Global Poultry Coccidiosis Vaccines Revenue by Region: 2021–2032
3.3.1 Global Poultry Coccidiosis Vaccines Revenue by Region: 2021–2026
3.3.2 Global Poultry Coccidiosis Vaccines Revenue by Region: 2027–2032
3.4 North America Poultry Coccidiosis Vaccines Market Facts & Figures by Country
3.4.1 North America Poultry Coccidiosis Vaccines Market Size by Country: 2021 vs 2025 vs 2032
3.4.2 North America Poultry Coccidiosis Vaccines Sales by Country (2021–2032)
3.4.3 North America Poultry Coccidiosis Vaccines Revenue by Country (2021–2032)
3.4.4 United States
3.4.5 Canada
3.5 Europe Poultry Coccidiosis Vaccines Market Facts & Figures by Country
3.5.1 Europe Poultry Coccidiosis Vaccines Market Size by Country: 2021 vs 2025 vs 2032
3.5.2 Europe Poultry Coccidiosis Vaccines Sales by Country (2021–2032)
3.5.3 Europe Poultry Coccidiosis Vaccines Revenue by Country (2021–2032)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Poultry Coccidiosis Vaccines Market Facts & Figures by Region
3.6.1 Asia Pacific Poultry Coccidiosis Vaccines Market Size by Region: 2021 vs 2025 vs 2032
3.6.2 Asia Pacific Poultry Coccidiosis Vaccines Sales by Region (2021–2032)
3.6.3 Asia Pacific Poultry Coccidiosis Vaccines Revenue by Region (2021–2032)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America Poultry Coccidiosis Vaccines Market Facts & Figures by Country
3.7.1 Latin America Poultry Coccidiosis Vaccines Market Size by Country: 2021 vs 2025 vs 2032
3.7.2 Latin America Poultry Coccidiosis Vaccines Sales by Country (2021–2032)
3.7.3 Latin America Poultry Coccidiosis Vaccines Revenue by Country (2021–2032)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.7.7 Colombia
3.8 Middle East and Africa Poultry Coccidiosis Vaccines Market Facts & Figures by Country
3.8.1 Middle East and Africa Poultry Coccidiosis Vaccines Market Size by Country: 2021 vs 2025 vs 2032
3.8.2 Middle East and Africa Poultry Coccidiosis Vaccines Sales by Country (2021–2032)
3.8.3 Middle East and Africa Poultry Coccidiosis Vaccines Revenue by Country (2021–2032)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Poultry Coccidiosis Vaccines Sales by Type (2021–2032)
4.1.1 Global Poultry Coccidiosis Vaccines Sales by Type (2021–2026)
4.1.2 Global Poultry Coccidiosis Vaccines Sales by Type (2027–2032)
4.1.3 Global Poultry Coccidiosis Vaccines Sales Market Share by Type (2021–2032)
4.2 Global Poultry Coccidiosis Vaccines Revenue by Type (2021–2032)
4.2.1 Global Poultry Coccidiosis Vaccines Revenue by Type (2021–2026)
4.2.2 Global Poultry Coccidiosis Vaccines Revenue by Type (2027–2032)
4.2.3 Global Poultry Coccidiosis Vaccines Revenue Market Share by Type (2021–2032)
4.3 Global Poultry Coccidiosis Vaccines Price by Type (2021–2032)
5 Segment by Application
5.1 Global Poultry Coccidiosis Vaccines Sales by Application (2021–2032)
5.1.1 Global Poultry Coccidiosis Vaccines Sales by Application (2021–2026)
5.1.2 Global Poultry Coccidiosis Vaccines Sales by Application (2027–2032)
5.1.3 Global Poultry Coccidiosis Vaccines Sales Market Share by Application (2021–2032)
5.2 Global Poultry Coccidiosis Vaccines Revenue by Application (2021–2032)
5.2.1 Global Poultry Coccidiosis Vaccines Revenue by Application (2021–2026)
5.2.2 Global Poultry Coccidiosis Vaccines Revenue by Application (2027–2032)
5.2.3 Global Poultry Coccidiosis Vaccines Revenue Market Share by Application (2021–2032)
5.3 Global Poultry Coccidiosis Vaccines Price by Application (2021–2032)
6 Key Companies Profiled
6.1 MSD Animal Health
6.1.1 MSD Animal Health Company Information
6.1.2 MSD Animal Health Description and Business Overview
6.1.3 MSD Animal Health Poultry Coccidiosis Vaccines Sales, Revenue, and Gross Margin (2021–2026)
6.1.4 MSD Animal Health Poultry Coccidiosis Vaccines Product Portfolio
6.1.5 MSD Animal Health Recent Developments/Updates
6.2 Boehringer Ingelheim
6.2.1 Boehringer Ingelheim Company Information
6.2.2 Boehringer Ingelheim Description and Business Overview
6.2.3 Boehringer Ingelheim Poultry Coccidiosis Vaccines Sales, Revenue, and Gross Margin (2021–2026)
6.2.4 Boehringer Ingelheim Poultry Coccidiosis Vaccines Product Portfolio
6.2.5 Boehringer Ingelheim Recent Developments/Updates
6.3 HIPRA
6.3.1 HIPRA Company Information
6.3.2 HIPRA Description and Business Overview
6.3.3 HIPRA Poultry Coccidiosis Vaccines Sales, Revenue, and Gross Margin (2021–2026)
6.3.4 HIPRA Poultry Coccidiosis Vaccines Product Portfolio
6.3.5 HIPRA Recent Developments/Updates
6.4 Bioproperties
6.4.1 Bioproperties Company Information
6.4.2 Bioproperties Description and Business Overview
6.4.3 Bioproperties Poultry Coccidiosis Vaccines Sales, Revenue, and Gross Margin (2021–2026)
6.4.4 Bioproperties Poultry Coccidiosis Vaccines Product Portfolio
6.4.5 Bioproperties Recent Developments/Updates
6.5 Huvepharma
6.5.1 Huvepharma Company Information
6.5.2 Huvepharma Description and Business Overview
6.5.3 Huvepharma Poultry Coccidiosis Vaccines Sales, Revenue, and Gross Margin (2021–2026)
6.5.4 Huvepharma Poultry Coccidiosis Vaccines Product Portfolio
6.5.5 Huvepharma Recent Developments/Updates
6.6 Nisseiken
6.6.1 Nisseiken Company Information
6.6.2 Nisseiken Description and Business Overview
6.6.3 Nisseiken Poultry Coccidiosis Vaccines Sales, Revenue, and Gross Margin (2021–2026)
6.6.4 Nisseiken Poultry Coccidiosis Vaccines Product Portfolio
6.6.5 Nisseiken Recent Developments/Updates
6.7 Biopharm
6.7.1 Biopharm Company Information
6.7.2 Biopharm Description and Business Overview
6.7.3 Biopharm Poultry Coccidiosis Vaccines Sales, Revenue, and Gross Margin (2021–2026)
6.7.4 Biopharm Poultry Coccidiosis Vaccines Product Portfolio
6.7.5 Biopharm Recent Developments/Updates
6.8 Ceva Santé Animale
6.8.1 Ceva Santé Animale Company Information
6.8.2 Ceva Santé Animale Description and Business Overview
6.8.3 Ceva Santé Animale Poultry Coccidiosis Vaccines Sales, Revenue, and Gross Margin (2021–2026)
6.8.4 Ceva Santé Animale Poultry Coccidiosis Vaccines Product Portfolio
6.8.5 Ceva Santé Animale Recent Developments/Updates
6.9 Vaxxinova
6.9.1 Vaxxinova Company Information
6.9.2 Vaxxinova Description and Business Overview
6.9.3 Vaxxinova Poultry Coccidiosis Vaccines Sales, Revenue, and Gross Margin (2021–2026)
6.9.4 Vaxxinova Poultry Coccidiosis Vaccines Product Portfolio
6.9.5 Vaxxinova Recent Developments/Updates
6.10 Foshan Standard Biotech
6.10.1 Foshan Standard Biotech Company Information
6.10.2 Foshan Standard Biotech Description and Business Overview
6.10.3 Foshan Standard Biotech Poultry Coccidiosis Vaccines Sales, Revenue, and Gross Margin (2021–2026)
6.10.4 Foshan Standard Biotech Poultry Coccidiosis Vaccines Product Portfolio
6.10.5 Foshan Standard Biotech Recent Developments/Updates
6.11 Qilu Qingda Bio-Pharmaceutical
6.11.1 Qilu Qingda Bio-Pharmaceutical Company Information
6.11.2 Qilu Qingda Bio-Pharmaceutical Description and Business Overview
6.11.3 Qilu Qingda Bio-Pharmaceutical Poultry Coccidiosis Vaccines Sales, Revenue, and Gross Margin (2021–2026)
6.11.4 Qilu Qingda Bio-Pharmaceutical Poultry Coccidiosis Vaccines Product Portfolio
6.11.5 Qilu Qingda Bio-Pharmaceutical Recent Developments/Updates
6.12 Skystar Bio-pharm
6.12.1 Skystar Bio-pharm Company Information
6.12.2 Skystar Bio-pharm Description and Business Overview
6.12.3 Skystar Bio-pharm Poultry Coccidiosis Vaccines Sales, Revenue, and Gross Margin (2021–2026)
6.12.4 Skystar Bio-pharm Poultry Coccidiosis Vaccines Product Portfolio
6.12.5 Skystar Bio-pharm Recent Developments/Updates
6.13 Hlinte
6.13.1 Hlinte Company Information
6.13.2 Hlinte Description and Business Overview
6.13.3 Hlinte Poultry Coccidiosis Vaccines Sales, Revenue, and Gross Margin (2021–2026)
6.13.4 Hlinte Poultry Coccidiosis Vaccines Product Portfolio
6.13.5 Hlinte Recent Developments/Updates
6.14 Guangdong Winsun Bio-pharmaceutical
6.14.1 Guangdong Winsun Bio-pharmaceutical Company Information
6.14.2 Guangdong Winsun Bio-pharmaceutical Description and Business Overview
6.14.3 Guangdong Winsun Bio-pharmaceutical Poultry Coccidiosis Vaccines Sales, Revenue, and Gross Margin (2021–2026)
6.14.4 Guangdong Winsun Bio-pharmaceutical Poultry Coccidiosis Vaccines Product Portfolio
6.14.5 Guangdong Winsun Bio-pharmaceutical Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Poultry Coccidiosis Vaccines Industry Chain Analysis
7.2 Poultry Coccidiosis Vaccines Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Poultry Coccidiosis Vaccines Production Mode & Process Analysis
7.4 Poultry Coccidiosis Vaccines Sales and Marketing
7.4.1 Poultry Coccidiosis Vaccines Sales Channels
7.4.2 Poultry Coccidiosis Vaccines Distributors
7.5 Poultry Coccidiosis Vaccines Customer Analysis
8 Poultry Coccidiosis Vaccines Market Dynamics
8.1 Poultry Coccidiosis Vaccines Industry Trends
8.2 Poultry Coccidiosis Vaccines Market Drivers
8.3 Poultry Coccidiosis Vaccines Market Challenges
8.4 Poultry Coccidiosis Vaccines Market Restraints
8.5 Impact of U.S. Tariffs
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of Tables
 Table 1. Global Poultry Coccidiosis Vaccines Market Value by Type (US$ Million), 2025 vs 2032
 Table 2. Global Poultry Coccidiosis Vaccines Market Value by Application (US$ Million), 2025 vs 2032
 Table 3. Global Poultry Coccidiosis Vaccines Market Competitive Situation by Manufacturers in 2025
 Table 4. Global Poultry Coccidiosis Vaccines Sales (K Units) of Key Manufacturers (2021–2026)
 Table 5. Global Poultry Coccidiosis Vaccines Sales Market Share by Manufacturers (2021–2026)
 Table 6. Global Poultry Coccidiosis Vaccines Revenue (US$ Million) by Manufacturers (2021–2026)
 Table 7. Global Poultry Coccidiosis Vaccines Revenue Share by Manufacturers (2021–2026)
 Table 8. Global Market Poultry Coccidiosis Vaccines Average Price (US$/Unit) of Key Manufacturers (2021–2026)
 Table 9. Global Key Players of Poultry Coccidiosis Vaccines, Industry Ranking, 2023 vs 2024 vs 2025
 Table 10. Global Key Manufacturers of Poultry Coccidiosis Vaccines, Manufacturing Sites and Headquarters
 Table 11. Global Key Manufacturers of Poultry Coccidiosis Vaccines, Product Types and Applications
 Table 12. Global Key Manufacturers of Poultry Coccidiosis Vaccines, Date of Entry into the Industry
 Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
 Table 14. Global Poultry Coccidiosis Vaccines Companies by Tier (Tier 1, Tier 2, Tier 3), based on Poultry Coccidiosis Vaccines Revenue, 2025
 Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
 Table 16. Global Poultry Coccidiosis Vaccines Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
 Table 17. Global Poultry Coccidiosis Vaccines Sales by Region (K Units), 2021–2026
 Table 18. Global Poultry Coccidiosis Vaccines Sales Market Share by Region (2021–2026)
 Table 19. Global Poultry Coccidiosis Vaccines Sales by Region (K Units), 2027–2032
 Table 20. Global Poultry Coccidiosis Vaccines Sales Market Share by Region (2027–2032)
 Table 21. Global Poultry Coccidiosis Vaccines Revenue by Region (US$ Million), 2021–2026
 Table 22. Global Poultry Coccidiosis Vaccines Revenue Market Share by Region (2021–2026)
 Table 23. Global Poultry Coccidiosis Vaccines Revenue by Region (US$ Million), 2027–2032
 Table 24. Global Poultry Coccidiosis Vaccines Revenue Market Share by Region (2027–2032)
 Table 25. North America Poultry Coccidiosis Vaccines Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
 Table 26. North America Poultry Coccidiosis Vaccines Sales by Country (K Units), 2021–2026
 Table 27. North America Poultry Coccidiosis Vaccines Sales by Country (K Units), 2027–2032
 Table 28. North America Poultry Coccidiosis Vaccines Revenue by Country (US$ Million), 2021–2026
 Table 29. North America Poultry Coccidiosis Vaccines Revenue by Country (US$ Million), 2027–2032
 Table 30. Europe Poultry Coccidiosis Vaccines Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
 Table 31. Europe Poultry Coccidiosis Vaccines Sales by Country (K Units), 2021–2026
 Table 32. Europe Poultry Coccidiosis Vaccines Sales by Country (K Units), 2027–2032
 Table 33. Europe Poultry Coccidiosis Vaccines Revenue by Country (US$ Million), 2021–2026
 Table 34. Europe Poultry Coccidiosis Vaccines Revenue by Country (US$ Million), 2027–2032
 Table 35. Asia Pacific Poultry Coccidiosis Vaccines Revenue by Region: 2021 vs 2025 vs 2032 (US$ Million)
 Table 36. Asia Pacific Poultry Coccidiosis Vaccines Sales by Region (K Units), 2021–2026
 Table 37. Asia Pacific Poultry Coccidiosis Vaccines Sales by Region (K Units), 2027–2032
 Table 38. Asia Pacific Poultry Coccidiosis Vaccines Revenue by Region (US$ Million), 2021–2026
 Table 39. Asia Pacific Poultry Coccidiosis Vaccines Revenue by Region (US$ Million), 2027–2032
 Table 40. Latin America Poultry Coccidiosis Vaccines Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
 Table 41. Latin America Poultry Coccidiosis Vaccines Sales by Country (K Units), 2021–2026
 Table 42. Latin America Poultry Coccidiosis Vaccines Sales by Country (K Units), 2027–2032
 Table 43. Latin America Poultry Coccidiosis Vaccines Revenue by Country (US$ Million), 2021–2026
 Table 44. Latin America Poultry Coccidiosis Vaccines Revenue by Country (US$ Million), 2027–2032
 Table 45. Middle East and Africa Poultry Coccidiosis Vaccines Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
 Table 46. Middle East and Africa Poultry Coccidiosis Vaccines Sales by Country (K Units), 2021–2026
 Table 47. Middle East and Africa Poultry Coccidiosis Vaccines Sales by Country (K Units), 2027–2032
 Table 48. Middle East and Africa Poultry Coccidiosis Vaccines Revenue by Country (US$ Million), 2021–2026
 Table 49. Middle East and Africa Poultry Coccidiosis Vaccines Revenue by Country (US$ Million), 2027–2032
 Table 50. Global Poultry Coccidiosis Vaccines Sales (K Units) by Type (2021–2026)
 Table 51. Global Poultry Coccidiosis Vaccines Sales (K Units) by Type (2027–2032)
 Table 52. Global Poultry Coccidiosis Vaccines Sales Market Share by Type (2021–2026)
 Table 53. Global Poultry Coccidiosis Vaccines Sales Market Share by Type (2027–2032)
 Table 54. Global Poultry Coccidiosis Vaccines Revenue (US$ Million) by Type (2021–2026)
 Table 55. Global Poultry Coccidiosis Vaccines Revenue (US$ Million) by Type (2027–2032)
 Table 56. Global Poultry Coccidiosis Vaccines Revenue Market Share by Type (2021–2026)
 Table 57. Global Poultry Coccidiosis Vaccines Revenue Market Share by Type (2027–2032)
 Table 58. Global Poultry Coccidiosis Vaccines Price (US$/Unit) by Type (2021–2026)
 Table 59. Global Poultry Coccidiosis Vaccines Price (US$/Unit) by Type (2027–2032)
 Table 60. Global Poultry Coccidiosis Vaccines Sales (K Units) by Application (2021–2026)
 Table 61. Global Poultry Coccidiosis Vaccines Sales (K Units) by Application (2027–2032)
 Table 62. Global Poultry Coccidiosis Vaccines Sales Market Share by Application (2021–2026)
 Table 63. Global Poultry Coccidiosis Vaccines Sales Market Share by Application (2027–2032)
 Table 64. Global Poultry Coccidiosis Vaccines Revenue (US$ Million) by Application (2021–2026)
 Table 65. Global Poultry Coccidiosis Vaccines Revenue (US$ Million) by Application (2027–2032)
 Table 66. Global Poultry Coccidiosis Vaccines Revenue Market Share by Application (2021–2026)
 Table 67. Global Poultry Coccidiosis Vaccines Revenue Market Share by Application (2027–2032)
 Table 68. Global Poultry Coccidiosis Vaccines Price (US$/Unit) by Application (2021–2026)
 Table 69. Global Poultry Coccidiosis Vaccines Price (US$/Unit) by Application (2027–2032)
 Table 70. MSD Animal Health Company Information
 Table 71. MSD Animal Health Description and Business Overview
 Table 72. MSD Animal Health Poultry Coccidiosis Vaccines Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 73. MSD Animal Health Poultry Coccidiosis Vaccines Product
 Table 74. MSD Animal Health Recent Developments/Updates
 Table 75. Boehringer Ingelheim Company Information
 Table 76. Boehringer Ingelheim Description and Business Overview
 Table 77. Boehringer Ingelheim Poultry Coccidiosis Vaccines Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 78. Boehringer Ingelheim Poultry Coccidiosis Vaccines Product
 Table 79. Boehringer Ingelheim Recent Developments/Updates
 Table 80. HIPRA Company Information
 Table 81. HIPRA Description and Business Overview
 Table 82. HIPRA Poultry Coccidiosis Vaccines Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 83. HIPRA Poultry Coccidiosis Vaccines Product
 Table 84. HIPRA Recent Developments/Updates
 Table 85. Bioproperties Company Information
 Table 86. Bioproperties Description and Business Overview
 Table 87. Bioproperties Poultry Coccidiosis Vaccines Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 88. Bioproperties Poultry Coccidiosis Vaccines Product
 Table 89. Bioproperties Recent Developments/Updates
 Table 90. Huvepharma Company Information
 Table 91. Huvepharma Description and Business Overview
 Table 92. Huvepharma Poultry Coccidiosis Vaccines Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 93. Huvepharma Poultry Coccidiosis Vaccines Product
 Table 94. Huvepharma Recent Developments/Updates
 Table 95. Nisseiken Company Information
 Table 96. Nisseiken Description and Business Overview
 Table 97. Nisseiken Poultry Coccidiosis Vaccines Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 98. Nisseiken Poultry Coccidiosis Vaccines Product
 Table 99. Nisseiken Recent Developments/Updates
 Table 100. Biopharm Company Information
 Table 101. Biopharm Description and Business Overview
 Table 102. Biopharm Poultry Coccidiosis Vaccines Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 103. Biopharm Poultry Coccidiosis Vaccines Product
 Table 104. Biopharm Recent Developments/Updates
 Table 105. Ceva Santé Animale Company Information
 Table 106. Ceva Santé Animale Description and Business Overview
 Table 107. Ceva Santé Animale Poultry Coccidiosis Vaccines Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 108. Ceva Santé Animale Poultry Coccidiosis Vaccines Product
 Table 109. Ceva Santé Animale Recent Developments/Updates
 Table 110. Vaxxinova Company Information
 Table 111. Vaxxinova Description and Business Overview
 Table 112. Vaxxinova Poultry Coccidiosis Vaccines Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 113. Vaxxinova Poultry Coccidiosis Vaccines Product
 Table 114. Vaxxinova Recent Developments/Updates
 Table 115. Foshan Standard Biotech Company Information
 Table 116. Foshan Standard Biotech Description and Business Overview
 Table 117. Foshan Standard Biotech Poultry Coccidiosis Vaccines Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 118. Foshan Standard Biotech Poultry Coccidiosis Vaccines Product
 Table 119. Foshan Standard Biotech Recent Developments/Updates
 Table 120. Qilu Qingda Bio-Pharmaceutical Company Information
 Table 121. Qilu Qingda Bio-Pharmaceutical Description and Business Overview
 Table 122. Qilu Qingda Bio-Pharmaceutical Poultry Coccidiosis Vaccines Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 123. Qilu Qingda Bio-Pharmaceutical Poultry Coccidiosis Vaccines Product
 Table 124. Qilu Qingda Bio-Pharmaceutical Recent Developments/Updates
 Table 125. Skystar Bio-pharm Company Information
 Table 126. Skystar Bio-pharm Description and Business Overview
 Table 127. Skystar Bio-pharm Poultry Coccidiosis Vaccines Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 128. Skystar Bio-pharm Poultry Coccidiosis Vaccines Product
 Table 129. Skystar Bio-pharm Recent Developments/Updates
 Table 130. Hlinte Company Information
 Table 131. Hlinte Description and Business Overview
 Table 132. Hlinte Poultry Coccidiosis Vaccines Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 133. Hlinte Poultry Coccidiosis Vaccines Product
 Table 134. Hlinte Recent Developments/Updates
 Table 135. Guangdong Winsun Bio-pharmaceutical Company Information
 Table 136. Guangdong Winsun Bio-pharmaceutical Description and Business Overview
 Table 137. Guangdong Winsun Bio-pharmaceutical Poultry Coccidiosis Vaccines Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 138. Guangdong Winsun Bio-pharmaceutical Poultry Coccidiosis Vaccines Product
 Table 139. Guangdong Winsun Bio-pharmaceutical Recent Developments/Updates
 Table 140. Key Raw Materials Lists
 Table 141. Raw Materials Key Suppliers Lists
 Table 142. Poultry Coccidiosis Vaccines Distributors List
 Table 143. Poultry Coccidiosis Vaccines Customers List
 Table 144. Poultry Coccidiosis Vaccines Market Trends
 Table 145. Poultry Coccidiosis Vaccines Market Drivers
 Table 146. Poultry Coccidiosis Vaccines Market Challenges
 Table 147. Poultry Coccidiosis Vaccines Market Restraints
 Table 148. Research Programs/Design for This Report
 Table 149. Key Data Information from Secondary Sources
 Table 150. Key Data Information from Primary Sources
 Table 151. Authors List of This Report


List of Figures
 Figure 1. Product Picture of Poultry Coccidiosis Vaccines
 Figure 2. Global Poultry Coccidiosis Vaccines Market Value by Type (US$ Million), 2021–2032
 Figure 3. Global Poultry Coccidiosis Vaccines Market Share by Type: 2025 & 2032
 Figure 4. Attenuated Vaccines Product Picture
 Figure 5. Non-attenuated Vaccines Product Picture
 Figure 6. Global Poultry Coccidiosis Vaccines Market Value by Application (US$ Million), 2021–2032
 Figure 7. Global Poultry Coccidiosis Vaccines Market Share by Application: 2025 & 2032
 Figure 8. Poultry
 Figure 9. Other Animals
 Figure 10. Global Poultry Coccidiosis Vaccines Revenue, (US$ Million), 2021 vs 2025 vs 2032
 Figure 11. Global Poultry Coccidiosis Vaccines Market Size (US$ Million), 2021–2032
 Figure 12. Global Poultry Coccidiosis Vaccines Sales (K Units), 2021–2032
 Figure 13. Global Poultry Coccidiosis Vaccines Average Price (US$/Unit), 2021–2032
 Figure 14. Poultry Coccidiosis Vaccines Report Years Considered
 Figure 15. Poultry Coccidiosis Vaccines Sales Share by Manufacturers in 2025
 Figure 16. Global Poultry Coccidiosis Vaccines Revenue Share by Manufacturers in 2025
 Figure 17. Top 5 and Top 10 Global Poultry Coccidiosis Vaccines Players: Market Share by Revenue in Poultry Coccidiosis Vaccines in 2025
 Figure 18. Poultry Coccidiosis Vaccines Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2021 vs 2025
 Figure 19. Global Poultry Coccidiosis Vaccines Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
 Figure 20. North America Poultry Coccidiosis Vaccines Sales Market Share by Country (2021–2032)
 Figure 21. North America Poultry Coccidiosis Vaccines Revenue Market Share by Country (2021–2032)
 Figure 22. United States Poultry Coccidiosis Vaccines Revenue Growth Rate (US$ Million), 2021–2032
 Figure 23. Canada Poultry Coccidiosis Vaccines Revenue Growth Rate (US$ Million), 2021–2032
 Figure 24. Europe Poultry Coccidiosis Vaccines Sales Market Share by Country (2021–2032)
 Figure 25. Europe Poultry Coccidiosis Vaccines Revenue Market Share by Country (2021–2032)
 Figure 26. Germany Poultry Coccidiosis Vaccines Revenue Growth Rate (US$ Million), 2021–2032
 Figure 27. France Poultry Coccidiosis Vaccines Revenue Growth Rate (US$ Million), 2021–2032
 Figure 28. U.K. Poultry Coccidiosis Vaccines Revenue Growth Rate (US$ Million), 2021–2032
 Figure 29. Italy Poultry Coccidiosis Vaccines Revenue Growth Rate (US$ Million), 2021–2032
 Figure 30. Russia Poultry Coccidiosis Vaccines Revenue Growth Rate (US$ Million), 2021–2032
 Figure 31. Asia Pacific Poultry Coccidiosis Vaccines Sales Market Share by Region (2021–2032)
 Figure 32. Asia Pacific Poultry Coccidiosis Vaccines Revenue Market Share by Region (2021–2032)
 Figure 33. China Poultry Coccidiosis Vaccines Revenue Growth Rate (US$ Million), 2021–2032
 Figure 34. Japan Poultry Coccidiosis Vaccines Revenue Growth Rate (US$ Million), 2021–2032
 Figure 35. South Korea Poultry Coccidiosis Vaccines Revenue Growth Rate (US$ Million), 2021–2032
 Figure 36. India Poultry Coccidiosis Vaccines Revenue Growth Rate (US$ Million), 2021–2032
 Figure 37. Australia Poultry Coccidiosis Vaccines Revenue Growth Rate (US$ Million), 2021–2032
 Figure 38. China Taiwan Poultry Coccidiosis Vaccines Revenue Growth Rate (US$ Million), 2021–2032
 Figure 39. Southeast Asia Poultry Coccidiosis Vaccines Revenue Growth Rate (US$ Million), 2021–2032
 Figure 40. Latin America Poultry Coccidiosis Vaccines Sales Market Share by Country (2021–2032)
 Figure 41. Latin America Poultry Coccidiosis Vaccines Revenue Market Share by Country (2021–2032)
 Figure 42. Mexico Poultry Coccidiosis Vaccines Revenue Growth Rate (US$ Million), 2021–2032
 Figure 43. Brazil Poultry Coccidiosis Vaccines Revenue Growth Rate (US$ Million), 2021–2032
 Figure 44. Argentina Poultry Coccidiosis Vaccines Revenue Growth Rate (US$ Million), 2021–2032
 Figure 45. Colombia Poultry Coccidiosis Vaccines Revenue Growth Rate (US$ Million), 2021–2032
 Figure 46. Middle East and Africa Poultry Coccidiosis Vaccines Sales Market Share by Country (2021–2032)
 Figure 47. Middle East and Africa Poultry Coccidiosis Vaccines Revenue Market Share by Country (2021–2032)
 Figure 48. Turkey Poultry Coccidiosis Vaccines Revenue Growth Rate (US$ Million), 2021–2032
 Figure 49. Saudi Arabia Poultry Coccidiosis Vaccines Revenue Growth Rate (US$ Million), 2021–2032
 Figure 50. UAE Poultry Coccidiosis Vaccines Revenue Growth Rate (US$ Million), 2021–2032
 Figure 51. Global Sales Market Share of Poultry Coccidiosis Vaccines by Type (2021–2032)
 Figure 52. Global Revenue Market Share of Poultry Coccidiosis Vaccines by Type (2021–2032)
 Figure 53. Global Poultry Coccidiosis Vaccines Price (US$/Unit) by Type (2021–2032)
 Figure 54. Global Sales Market Share of Poultry Coccidiosis Vaccines by Application (2021–2032)
 Figure 55. Global Revenue Market Share of Poultry Coccidiosis Vaccines by Application (2021–2032)
 Figure 56. Global Poultry Coccidiosis Vaccines Price (US$/Unit) by Application (2021–2032)
 Figure 57. Poultry Coccidiosis Vaccines Value Chain
 Figure 58. Channels of Distribution (Direct Vs Distribution)
 Figure 59. Bottom-up and Top-down Approaches for This Report
 Figure 60. Data Triangulation
 Figure 61. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic

$2900

Single User License
Electronic

$4350

Multi User License
Electronic

$5800

Enterprise License
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

Accenture